FdaApplication
NDA 212526
Identifiers
- fda_app_no: NDA212526
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2019-05-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PIQRAY | ALPELISIB | 150MG | TABLET;ORAL |
| PIQRAY | ALPELISIB | 50MG | TABLET;ORAL |
| PIQRAY | ALPELISIB | 200MG | TABLET;ORAL |
3 products